Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia

Atherosclerosis

Volumn 252, Issue , 2016, Pages 21-27

  Torvik, Kristin ^a,b   Narverud, Ingunn ^a   Ottestad, Inger ^a   Svilaas, Arne ^b   Gran, Jon Michael ^a   Retterstøl, Kjetil ^a,b   Ellingvåg, Asta ^b   Strøm, Ellen ^b   Ose, Leiv ^a   Veierød, Marit B ^a   Holven, Kirsten B ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Children; Diet; Dietary fat; Familial hypercholesterolemia; Plasma cholesterol levels

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PHYTOSTEROL; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRACE ELEMENT; VITAMIN D; FATTY ACID; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY SUPPLEMENT; ESTRADIOL BLOOD LEVEL; FAMILIAL HYPERCHOLESTEROLEMIA; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL COUNSELING; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SEX DIFFERENCE; ADMINISTRATION AND DOSAGE; BLOOD; CHOLESTEROL INTAKE; COUNSELING; DIET; DIET THERAPY; MEDICAL RECORD; PRESCHOOL CHILD;

ADOLESCENT; APOLIPOPROTEINS B; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COUNSELING; DIET; DIET RECORDS; DIETARY FATS; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; MALE; TRIGLYCERIDES;

EID: 84979986244     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.07.913     Document Type: Article

References (51)

1. [1] Brown, M.S., Goldstein, J.L., A receptor-mediated pathway for cholesterol homeostasis. Sci. (New York, NY) 232:4746 (1986), 34–47.
2. [2] Hobbs, H.H., Brown, M.S., Goldstein, J.L., Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1:6 (1992), 445–466.
3. [3] Nordestgaard, B.G., Chapman, M.J., Humphries, S.E., Ginsberg, H.N., Masana, L., Descamps, O.S., et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 34:45 (2013), 3478–3490a.
4. [4] Wiegman, A., Gidding, S.S., Watts, G.F., Chapman, M.J., Ginsberg, H.N., Cuchel, M., et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur. heart J. 36:36 (2015), 2425–2437.
5. [5] Fat and Fatty acids, Nordic Nutrition Recommendations 2012-Integrating Nutrition and Physical Activity, fifth ed., 2014, Nordic Council of Ministers, Copenhagen.
6. [6] Daniels, S.R., Gidding, S.S., de Ferranti, S.D., Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J. Clin. Lipidol. 5:3 (2011), S30–S37.
7. [7] Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama 285:19 (2001), 2486–2497.
8. [8] Goldberg, A.C., Hopkins, P.N., Toth, P.P., Ballantyne, C.M., Rader, D.J., Robinson, J.G., et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J. Clin. Lipidol. 5:3 (2011), S1–S8.
9. [9] Jenkins, D.J., Josse, A.R., Wong, J.M., Nguyen, T.H., Kendall, C.W., The portfolio diet for cardiovascular risk reduction. Curr. Atheroscler. Rep. 9:6 (2007), 501–507.
10. [10] Jenkins, D.J., Kendall, C.W., Faulkner, D., Vidgen, E., Trautwein, E.A., Parker, T.L., et al. A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metab. Clin. Exp. 51:12 (2002), 1596–1604.
11. [11] Jenkins, D.J., Kendall, C.W., Marchie, A., Faulkner, D.A., Wong, J.M., de Souza, R., et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. Jama 290:4 (2003), 502–510.
12. [12] Shafiq, N., Singh, M., Kaur, S., Khosla, P., Malhotra, S., Dietary treatment for familial hypercholesterolaemia. Cochrane Database Syst. Rev., 1, 2010, Cd001918.
13. [13] Katan, M.B., Grundy, S.M., Jones, P., Law, M., Miettinen, T., Paoletti, R., Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 78:8 (2003), 965–978.
14. [14] Austin, M.A., Hutter, C.M., Zimmern, R.L., Humphries, S.E., Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am. J. Epidemiol. 160:5 (2004), 407–420.
15. [15] Vuorela, N., Saha, M.T., Salo, M., Prevalence of overweight and obesity in 5- and 12-year-old Finnish children in 1986 and 2006. Acta Paediatr. (Oslo, Nor. 1992) 98:3 (2009), 507–512.
16. [16] Cole, T.J., Bellizzi, M.C., Flegal, K.M., Dietz, W.H., Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ Clin. Res. ed) 320:7244 (2000), 1240–1243.
17. [17] Juliusson, P.B., Roelants, M., Eide, G.E., Moster, D., Juul, A., Hauspie, R., et al. Growth references for Norwegian children (Trans.) Tidsskrift for den Norske laegeforening tidsskr. prakt. Med. ny raekke 129:4 (2009), 281–286.
18. [18] Andersen, L.F., Pollestad, M.L., Jacobs, D.R. Jr., Lovo, A., Hustvedt, B.E., Validation of a pre-coded food diary used among 13-year-olds: comparison of energy intake with energy expenditure. Public Health Nutr. 8:8 (2005), 1315–1321.
19. [19] Lillegaard, I.T., Andersen, L.F., Validation of a pre-coded food diary with energy expenditure, comparison of under-reporters v. acceptable reporters. Br. J. Nutr. 94:6 (2005), 998–1003.
20. [20] Lillegaard, I.T., Loken, E.B., Andersen, L.F., Relative validation of a pre-coded food diary among children, under-reporting varies with reporting day and time of the day. Eur. J. Clin. Nutr. 61:1 (2007), 61–68.
21. [21] Lillegaard, I.T., Overby, N.C., Andersen, L.F., Can children and adolescents use photographs of food to estimate portion sizes?. Eur. J. Clin. Nutr. 59:4 (2005), 611–617.
22. [22] Svilaas, A., Strom, E.C., Svilaas, T., Borgejordet, A., Thoresen, M., Ose, L., Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutrition, metabolism, and cardiovascular diseases. NMCD 12:2 (2002), 60–70.
23. [23] Molven, I., Retterstol, K., Andersen, L.F., Veierod, M.B., Narverud, I., Ose, L., et al. Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children. J. Nutr. Sci., 2, 2013, e32.
24. [24] R Core Team, R: a Language and Environment for Statistical Computing. 2014, R Foundation for Statistical Computing, Vienna, Austria http://www.R-project.org.
25. [25] Nordic Nutrition recommendations 2012-a summary. Nordic Nutrition Recommendations 2012-Integrating Nutrition and Physical Activity, fifth ed., 2014, Nordic Council of Ministers, Copenhagen.
26. [26] Jones, P., Kafonek, S., Laurora, I., Hunninghake, D., Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am. J. Cardiol. 81:5 (1998), 582–587.
27. [27] Law, M.R., Wald, N.J., Rudnicka, A.R., Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ Clin. Res. ed), 326(7404), 2003, 1423.
28. [28] Versmissen, J., Oosterveer, D.M., Yazdanpanah, M., Defesche, J.C., Basart, D.C., Liem, A.H., et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ Clin. Res. ed), 337, 2008, a2423.
29. [29] Connor, W.E., Connor, S.L., Importance of diet in the treatment of familial hypercholesterolemia. Am. J. Cardiol. 72:10 (1993), 42d–53d.
30. [30] Glassman, M., Spark, A., Berezin, S., Schwarz, S., Medow, M., Newman, L.J., Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation. Am. J. Dis. Child. (1960) 144:9 (1990), 973–976.
31. [31] Gulesserian, T., Widhalm, K., Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia. J. Am. Coll. Nutr. 21:2 (2002), 103–108.
32. [32] Negele, L., Schneider, B., Ristl, R., Stulnig, T.M., Willfort-Ehringer, A., Helk, O., et al. Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study. Eur. J. Clin. Nutr. 69:3 (2015), 337–343.
33. [33] Amundsen, A.L., Ntanios, F., Put, N., Ose, L., Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur. J. Clin. Nutr. 58:12 (2004), 1612–1620.
34. [34] Garoufi, A., Vorre, S., Soldatou, A., Tsentidis, C., Kossiva, L., Drakatos, A., et al. Plant sterols-enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective study. Ital. J. Pediatr., 40, 2014, 42.
35. [35] Guardamagna, O., Abello, F., Baracco, V., Federici, G., Bertucci, P., Mozzi, A., et al. Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption. Acta Diabetol. 48:2 (2011), 127–133.
36. [36] Gylling, H., Siimes, M.A., Miettinen, T.A., Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J. Lipid Res. 36:8 (1995), 1807–1812.
37. [37] Øverby, N.C., Andersen, L.F., UNGKOST-2000-Landsomfattende kostholdsundersøkelse blant elever i 4. og 8., 2002, klasse i Norge, Oslo Report number: IS-1019.
38. [38] Pedersen, A.N., Fagt, S., Groth, M.V., Christensen, T., Biltoft-Jensen, A., Matthiessen, J., et al. Danskernes kostvaner 2003-2008. 2010 Søborg.
39. [39] Barbieri, H.E., Pearson, M., Becker, W., Riksmaten - barn 2003: Livsmedels- och näringsinntag bland barn i Svergie. 2006 Uppsala.
40. [40] Patterson, E., Warnberg, J., Kearney, J., Sjostrom, M., The tracking of dietary intakes of children and adolescents in Sweden over six years: the European Youth Heart Study. Int. J. Behav. Nutr. Phys. Activity, 6, 2009, 91.
41. [41] Singer, M.R., Moore, L.L., Garrahie, E.J., Ellison, R.C., The tracking of nutrient intake in young children: the Framingham Children's Study. Am. J. Public Health 85:12 (1995), 1673–1677.
42. [42] Kwiterovich, P.O. Jr., Bachorik, P.S., Franklin, F.A. Jr., Margolis, S., Georgopoulos, L., Teng, B., et al. Effect of dietary treatment on the plasma levels of lipids, lipoprotein cholesterol and LDL B protein in children with type II hyperlipoproteinemia. Prog. Clin. Biol. Res. 188 (1985), 123–137.
43. [43] Mokuno, H., Yamada, N., Sugimoto, T., Kobayashi, T., Ishibashi, S., Shimano, H., et al. Cholesterol-free diet with a high ratio of polyunsaturated to saturated fatty acids in heterozygous familial hypercholesterolemia: significant lowering effect on plasma cholesterol. Horm. metab. Res. = Horm.- Stoffwechs. = Horm. metab. 22:4 (1990), 246–251.
44. [44] Polonsky, S.M., Bellet, P.S., Sprecher, D.L., Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment. Pediatrics 91:1 (1993), 92–96.
45. [45] Schlierf, G., Vogel, G., Heuck, C.C., Oster, P., Raetzer, H., Schellenberg, B., Dietary management of familial Hypercholesterolemia in Children and adolescents – a feasibility study. (author's transl) Monatsschrift Kinderheilkd. 125:8 (1977), 770–773.
46. [46] Nuotio, I.O., Raitakari, O.T., Porkka, K.V., Rasanen, L., Moilanen, T., Viikari, J.S., Associations between diet and the hyperapobetalipoproteinemia phenotype expression in children and young adults: the Cardiovascular Risk in Young Finns Study. Arterioscler., thromb., Vasc. Biol. 17:5 (1997), 820–825.
47. [47] Sala-Vila, A., Cofan, M., Mateo-Gallego, R., Cenarro, A., Civeira, F., Ros, E., Eicosapentaenoic acid in serum phospholipids relates to a less atherogenic lipoprotein profile in subjects with familial hypercholesterolemia. J. Nutr. Biochem. 24:9 (2013), 1604–1608.
48. [48] Tonstad, S., Leren, T.P., Sivertsen, M., Ose, L., Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler., thromb., Vasc. Biol. 15:8 (1995), 1009–1014.
49. [49] Cannon, C.P., Blazing, M.A., Giugliano, R.P., McCagg, A., White, J.A., Theroux, P., et al. Ezetimibe added to statin therapy after acute coronary syndromes. N. Engl. J. Med. 372:25 (2015), 2387–2397.
50. [50] Stitziel, N.O., Won, H.H., Morrison, A.C., Peloso, G.M., Do, R., Lange, L.A., et al. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371:22 (2014), 2072–2082.
51. [51] Tell, G.S., Mittelmark, M.B., Vellar, O.D., Cholesterol, high density lipoprotein cholesterol and triglycerides during puberty: the Oslo Youth Study. Am. J. Epidemiol. 122:5 (1985), 750–761.